No significant improvement of outcomes with EPA in COVID-19 - PACE-CME

No significant improvement of outcomes with EPA in COVID

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

FXIa inhibitor as a promising new anticoagulant drug
FXIa inhibitor as a promising new anticoagulant drug
AHA 2021
FXIa inhibitor as a promising new anticoagulant drug
- Prof. Jeffrey Weitz, MD
What is the effect of low-dose aspirin on dementia risk in T2DM?
What is the effect of low-dose aspirin on dementia risk in T2DM?
AHA 2021
What is the effect of low-dose aspirin on dementia risk in T2DM?
- Prof. Jane Armitage
Rigorous assessment of effect of individual triggers for AF
Rigorous assessment of effect of individual triggers for AF
AHA 2021
Rigorous assessment of effect of individual triggers for AF
- Prof. Gregory Marcus, MD
Ambitious project on use of non-physician providers to control BP
Ambitious project on use of non-physician providers to control BP
AHA 2021
Ambitious project on use of non-physician providers to control BP
- Prof. Keith Ferdinand, MD